Adiponectin is a promising candidate, and its serum level is a potential biomarker for predicting clinical outcomes in COPD and other complications, independent of the significant effects of the smoking status [18]. The gene discussed is ADIPOQ; the disease is chronic obstructive pulmonary disease.